InProTher announces €6M seed funding for first-in-class cancer immunotherapy drug
Danish early-stage biotech company InProTher has raised €6M seed funding from private investors to advance its lead drug candidate IPT001.
Archives for May 25, 2023
ReNAgade Therapeutics launches with $300M financing to unlock ‘limitless potential’ of RNA medicine
ReNAgade Therapeutics has announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures.
Immutep announces ‘promising’ new data for lung cancer treatment
Immutep, a clinical-stage biotech company developing immunotherapies for cancer and autoimmune disease, has announced encouraging new clinical data in first-line non-small cell lung cancer from INSIGHT-003.